                         SEQUENCE LISTING

<110>  The General Hospital Corporation
 
<120>  HER3 PEPTIDES FOR IMAGING AND RADIOTHERAPY

<130>  29539-0258WO1

<140>  PCT/US2017/069031
<141>  2017-12-29

<150>  62/440,052
<151>  2016-12-29

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding

<400>  1

Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   


<210>  2
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  peptide linker


<220>
<221>  misc_feature
<222>  (1)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  2

Xaa Xaa Xaa Xaa 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  peptide linker

<400>  3

Ala Gly Gly Gly 
1               


<210>  4
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (5)..(11)
<223>  Xaa can be any naturally occurring amino acid

<400>  4

Ala Gly Gly Gly Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10          


<210>  5
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  5

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  6
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  6

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  7
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding

<400>  7

Ala Gly Gly Gly Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   10              


<210>  8
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  terminal peptide modification to HER3 binding peptide


<220>
<221>  misc_feature
<222>  (1)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  8

Xaa Xaa Xaa Xaa 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  terminal peptide modification to HER3 binding peptide

<400>  9

Ala Gly Gly Gly 
1               


<210>  10
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  10

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  11
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding

<400>  11

Ala Gly Gly Gly Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   10              


<210>  12
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (2)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  12

Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (2)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  13

Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   


<210>  14
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  14

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  15
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  15

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  16
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  68Ga modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (6)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  16

Ala Gly Gly Gly Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10              


<210>  17
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  68Ga modified peptide for HER3 binding

<400>  17

Ala Gly Gly Gly Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   10              


<210>  18
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding

<400>  18

Ala Gly Gly Gly Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   10              


<210>  19
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding


<220>
<221>  misc_feature
<222>  (2)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  19

Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  peptide that binds HER3


<220>
<221>  misc_feature
<222>  (2)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  20

Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  modified peptide for HER3 binding

<400>  21

Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Unknown

<220>
<223>  peptide that binds HER3

<400>  22

Cys Leu Pro Thr Lys Phe Arg Ser Cys 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Unknown

<220>
<223>  peptide that does not demonstrate HER3 specific binding

<400>  23

Cys His Glu Gln Gln Asn Pro His Cys 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Unknown

<220>
<223>  peptide that does not demonstrate HER3 specific binding

<400>  24

Cys His Lys His Lys Asp Ser Gln Cys 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Unknown

<220>
<223>  peptide that does not demonstrate HER3 specific binding

<400>  25

Cys His Leu Gly Glu Met Gly His Cys 
1               5                   


